Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Publication of TW200626528ApublicationCriticalpatent/TW200626528A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention provides the benzenesulphonate salt of (1 α ,3 α ,5 α)-[3-(aminomethyl)bicyclo[3.2.0]hept-3-yl]acetic acid which has the following structural formula (II): This compound is particularly suitable as a drug substance and is useful in the treatment of pain, epilepsy and other conditions.
Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes